Thiago Domingos Corrêa

Thiago Domingos Corrêa

Auto-generated profile, based on publicly available information

Thiago Domingos Corrêa

Hospital Israelita Albert Einstein, São Paulo, SP, Brazil

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 October 2018 in Intensive Care Medicine
Verified
Journal Article
Closed access
PDF file
ANAry Serpa Neto
Ary Serpa Neto
RDRodrigo Octavio Deliberato
Rodrigo Octavio Deliberato
AJAlistair E. W. Johnson
Alistair E. W. Johnson
LBLieuwe D. Bos
Lieuwe D. Bos
PAPedro Amorim
Pedro Amorim
FIfor the PROVE Network Investigators
for the PROVE Network Investigators

28 September 2015 in Intensive Care Medicine
Verified
Journal Article
Closed access
PDF file
MSMarcio Soares
Marcio Soares
FBFernando Bozza
Fernando Bozza
DADerek C. Angus
Derek C. Angus
AJAndré M. Japiassú
André M. Japiassú
WVWilliam N. Viana
William N. Viana
JSJorge I. F. Salluh
Jorge I. F. Salluh

13 August 2018 in Intensive Care Medicine
Verified
Journal Article
Closed access
PDF file
FIfor the ORCHESTRA Study Investigators
for the ORCHESTRA Study Investigators
FZFernando G. Zampieri
Fernando G. Zampieri
TITheodore J. Iwashyna
Theodore J. Iwashyna
EVElizabeth M. Viglianti
Elizabeth M. Viglianti
LTLeandro U. Taniguchi
Leandro U. Taniguchi
MSMarcio Soares
Marcio Soares

20 September 2016 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
MSMarcio Soares
Marcio Soares
FBFernando Bozza
Fernando Bozza
LALuciano C.P. Azevedo
Luciano C.P. Azevedo
USUlysses V.A. Silva
Ulysses V.A. Silva
TCThiago D. Corrêa
Thiago D. Corrêa
JSJorge I.F. Salluh
Jorge I.F. Salluh
Purpose: To investigate the impact of organizational characteristics and processes of care on hospital mortality and resource use in patients with cancer admitted to intensive care units (ICUs). Patients and Methods: We performed a retrospective cohort study of 9,946 patients with cancer (solid, n = 8,956; hematologic, n = 990) admitted to 70 ICUs (51 located in general hospitals and 19 in cancer centers) during 2013. We retrieved patients’ clinical and outcome data from an electronic ICU quality registry. We surveyed ICUs regarding structure, organization, staffing patterns, and processes of care. We used mixed multivariable logistic regression analysis to identify characteristics associated with hospital mortality and efficient resource use in the ICU. Results: Median number of patients with cancer per center was 110 (interquartile range, 58 to 154), corresponding to 17.9% of all ICU admissions. ICU and hospital mortality rates were 15.9% and 25.4%, respectively. After adjusting for relevant patient characteristics, presence of clinical pharmacists in the ICU (odds ratio [OR], 0.67; 95% CI, 0.49 to 0.90), number of protocols (OR, 0.92; 95% CI, 0.87 to 0.98), and daily meetings between oncologists and intensivists for care planning (OR, 0.69; 95% CI, 0.52 to 0.91) were associated with lower mortality. Implementation of protocols (OR, 1.52; 95% CI, 1.11 to 2.07) and meetings between oncologists and intensivists (OR, 4.70; 95% CI, 1.15 to 19.22) were also independently associated with more efficient resource use. Neither admission to ICUs in cancer centers compared with general hospitals nor annual case volume had an impact on mortality or resource use. Conclusion: Organizational aspects, namely the implementation of protocols and presence of clinical pharmacists in the ICU, and close collaboration between oncologists and ICU teams are targets to improve mortality and resource use in critically ill patients with cancer.

1 November 2016 in Shock
Verified
Journal Article
Open access
PDF file
RFRoberto Rabello Filho
Roberto Rabello Filho
LRLeonardo Lima Rocha
Leonardo Lima Rocha
TCThiago Domingos Corrêa
Thiago Domingos Corrêa
CPCamila Menezes Souza Pessoa
Camila Menezes Souza Pessoa
GCGiancarlo Colombo
Giancarlo Colombo
MAMurillo Santucci Cesar Assuncao
Murillo Santucci Cesar Assuncao
The objective of this study was to identify the initial value of blood lactate that best correlates with 28-day mortality in resuscitated septic shock patients. This was a retrospective cohort study including 443 patients admitted to an intensive care unit (ICU) with severe sepsis or septic shock from the emergency department. A receiver-operating characteristic (ROC) curve was drawn to obtain the best cutoff value for initial blood lactate associated with 28-day mortality. Patients were then dichotomized according to the chosen lactate cutoff, and sensitivity, specificity, and positive and negative predictive values were calculated. Baseline blood lactate level more than 2.5 mmol/L showed the largest area under the ROC curve to predict 28-day mortality (ROC area, 0.70; 95% confidence interval [CI], 0.62–0.79), with sensitivity, specificity, and negative predictive value of 67.4%, 61.7%, and 94.2%, respectively. Mortality at 28 days was 16.9% (31/183) in patients with initial lactate more than 2.5 mmol/L and 5.8% (15/260) in patients with initial lactate at most 2.5 mmol/L (relative risk, 2.93; 95% CI, 1.63–5.28; P < 0.001). Initial blood lactate levels more than 2.5 mmol/L (hazard ratio [HR], 2.86; 95% CI, 1.53–5.33; P = 0.001) and Sepsis-related Organ Failure Assessment score at ICU admission (HR, 1.18; 95% CI, 1.09–1.27; P < 0.001) were associated with increased 28-day mortality in the adjusted Cox regression. In this retrospective cohort study, a lactate level more than 2.5 mmol/L was the best threshold to predict 28-day mortality among severe sepsis and septic shock patients. Further prospective studies should address the impact on morbidity and mortality of this threshold as a trigger to resuscitation in this population of critically ill patients.

1 August 2017 in Annals of the American Thoracic Society
Verified
Journal Article
Closed access
CPCarolina R. Ponzoni
Carolina R. Ponzoni
TCThiago D. Corrêa
Thiago D. Corrêa
RFRoberto Rabello Filho
Roberto Rabello Filho
ANAry Serpa Neto
Ary Serpa Neto
MAMurillo S. C. Assunção
Murillo S. C. Assunção
GSGuilherme P. P. Schettino
Guilherme P. P. Schettino
Rationale: Readmission to the intensive care unit (ICU) is associated with poor clinical outcomes, increased length of ICU and hospital stay, and higher costs. Nevertheless, knowledge of epidemiology of ICU readmissions, risk factors, and attributable outcomes is restricted to developed countries. Objectives: To determine the effect of ICU readmissions on in-hospital mortality, determine incidence of ICU readmissions, identify predictors of ICU readmissions and hospital mortality, and compare resource use and outcomes between readmitted and nonreadmitted patients in a developing country. Methods: This retrospective single-center cohort study was conducted in a 40-bed, open medical-surgical ICU of a private, tertiary care hospital in São Paulo, Brazil. The Local Ethics Committee at Hospital Israelita Albert Einstein approved the study protocol, and the need for informed consent was waived. All consecutive adult (≥18 yr) patients admitted to the ICU between June 1, 2013 and July 1, 2015 were enrolled in this study. Results: Comparisons were made between patients readmitted and not readmitted to the ICU. Logistic regression analyses were performed to identify predictors of ICU readmissions and hospital mortality. Out of 5,779 patients admitted to the ICU, 576 (10%) were readmitted to the ICU during the same hospitalization. Compared with nonreadmitted patients, patients readmitted to the ICU were more often men (349 of 576 patients [60.6%] vs. 2,919 of 5,203 patients [56.1%]; P = 0.042), showed a higher (median [interquartile range]) severity of illness (Simplified Acute Physiology III score) at index ICU admission (50 [41–61] vs. 42 [32–54], respectively, for readmitted and nonreadmitted patients; P < 0.001), and were more frequently admitted due to medical reasons (425 of 576 [73.8%] vs. 2,998 of 5,203 [57.6%], respectively, for readmitted and nonreadmitted patients; P < 0.001). Simplified Acute Physiology III score (P < 0.001), ICU admission from the ward (odds ratio [OR], 1.907; 95% confidence interval [CI], 1.463–2.487; P < 0.001), vasopressors need during index ICU stay (OR, 1.391; 95% CI, 1.130–1.713; P = 0.002), and length of ICU stay (P = 0.001) were independent predictors of ICU readmission. After adjusting for severity of illness, ICU readmission (OR, 4.103; 95% CI, 3.226–5.518; P < 0.001), admission source, presence of cancer, use of vasopressors, mechanical ventilation or renal replacement therapy, length of ICU stay, and nighttime ICU discharge were associated with increased risk of in-hospital death. Conclusions: Readmissions to the ICU were frequent and strongly related to poor outcomes. The degree to which ICU readmissions are preventable as well as the main causes of preventable ICU readmissions need to be further determined.